Blog

Yüksel Ürün: Critical intersections on androgen deprivation therapy (ADT) in prostate cancer treatment and cardiovascular health

Photo from Yüksel Ürün/X

May 6, 2024, 19:27

Yüksel Ürün: Critical intersections on androgen deprivation therapy (ADT) in prostate cancer treatment and cardiovascular health

Yüksel Ürün shared on Twitter/X:

“Critical intersections between androgen deprivation therapy (ADT) in prostate cancer treatment and cardiovascular health. Key points include:

1.ADT may aggravate common health issues such as hypertension and diabetes.
2.Regular cardiovascular risk assessments and ECG monitoring are recommended for patients on ADT.
3.For those with existing heart conditions, a GnRH antagonist could be beneficial.”

Source: Yüksel Ürün/X

Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey. His research focuses on genitourinary cancers, covering epidemiology, diagnosis, biomarkers, meta-analysis, and treatment outcomes. His dedication to patient care and research inspires positive change in the medical field.

ADT androgen deprivation therapy Ankara University School of Medicine cancer cancer treatment side effects cardiovascular health diabetes ECG GnRH GnRH antagonist hypertension Men's health OncoDaily Oncology Prostate cancer treatment Turkey

Immunotherapy for Melanoma: Types, Success Rate, Side Effects & More

Tom Green and Testicular Cancer: How He Went Against, How He Survived, and More

Steven O'Day: At the Forefront of Immunotherapy

Dennis Slamon was honored with the 2024 Szent-Györgyi Prize for Progress in Cancer Research

Pfizer is partnering with Patrick Dempsey in support of the American Cancer Society initiative 'Change the Odds'

Special Coverage